![](/img/cover-not-exists.png)
P207 Start of lumacaftor/ivacaftor in adult cystic fibrosis patients with homozygous F508del results in temporal and moderate changes in lung microbiome and metabolome
Neerincx, A.H., Whiteson, K., Phan, J.L., Brinkman, P., Abdel-Aziz, M.I., Weersink, E.J.M., Altenburg, J., Majoor, C., Maitland-van der Zee, A.H., Bos, L.D.J.Volume:
19
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(20)30541-5
Date:
June, 2020
File:
PDF, 57 KB
2020